Grabar Law Office Investigates Fiduciary Breach Claims Against Erasca, Insulet, Photronics, and Via Transportation

โดย GlobeNewswire·Read original
Summary · why it matters

Grabar Law Office is investigating potential fiduciary duty breaches by officers and directors of Erasca, Insulet, Photronics, and Via Transportation. The Erasca probe concerns disclosures about its pan-RAS molecular glue candidate ERAS-0015, including alleged improper comparisons to Revolution Medicines' RMC-6236 and undisclosed intellectual property risks; on April 27, 2026, the company disclosed patent infringement allegations and preliminary Phase 1 data showing a patient death, after which its share price fell substantially. The Insulet investigation relates to manufacturing defects that led to voluntary Medical Device Corrections for Omnipod 5, Omnipod Dash, and Omnipod Eros Pods on March 12 and May 26, 2026, due to a risk of insulin under-delivery. Photronics is being investigated over statements about strong demand for high-end IC photomask products that allegedly omitted stalled customer design releases caused by foundry utilization and cost pressures. The Via Transportation probe focuses on its September 15, 2025 IPO, with allegations that offering documents failed to disclose declining Platform Annual Run-Rate Revenue per customer and regulatory hurdles in Germany. Current long-term shareholders of each company may seek corporate governance reforms and damages through shareholder derivative actions at no personal cost.

Impact on assets 4

Biotech & Genomic Medicine▼ · 2 stocks
Erasca Inc
ERAS
▼ NegativeRegulationrelevance

Investigation over alleged improper disclosures and patent infringement; share price fell after disclosure.

Insulet Corporation
PODD
▼ NegativeRegulationrelevance

Investigation over manufacturing defects leading to voluntary Medical Device Corrections for Omnipod products.

Semiconductors▼ · 1 stocks
Photronics Inc
PLAB
▼ NegativeRegulationrelevance

Investigation over alleged omissions about stalled customer design releases due to foundry utilization and cost pressures.

Smart City / Autonomous Infrastructure▼ · 1 stocks
Via Transportation, Inc.
VIA
▼ NegativeRegulationrelevance

Investigation over alleged failure to disclose declining revenue per customer and regulatory hurdles in Germany at IPO.

© 2026 MarketDXNews